Funding
We gratefully acknowlege the following organizations for their funding/support for our research:
- NIH National Institute of Neurological Disorders and Stroke (NIH/NINDS)
- NIH National Cancer Institute (NIH/NCI)
- James S McDonnell Foundation
- Zell Family Foundation
- Lou & Jean Malnati Brain Tumor Institute at Northwestern
- Robert H Lurie Comprehensive Cancer Center
Our active grants include:
- Shi-Yuan Cheng, PhD, PI
- NIH/NINDS: 1R01NS115403-01A1
- Role of Protein Methylation in Cell Mitosis and Glioblastoma
- Shi-Yuan Cheng, PhD, PI
- NIH: 1R01NS125318-01A1
- Targeting RNA Splicing in Glioma
- Shi-Yuan Cheng, PhD, PI
- NIH, NINDS: R21, NS126819
- Cysteine Depletion-induced Ferroptosis as a Therapeutic Vulnerability in Glioblastoma Temozolomide Resistance
- Shi-Yuan Cheng, PhD, PI
- NIH, NINDS: R21, NS122375
- Target ATG4B to Treat Glioblastoma
- Deanna Marie Tiek, PhD, PI
- NIH/NCI: K99
- Ferroptosis in drug resistant glioma
- Deanna Marie Tiek, PhD, PI
- DOD: W81XWH-22-1-0373
- Targeting Chromothripsis in Malignant Glioma
- Xiao Song, PhD, PI
- DOD: W81XWH-22-1-0374
- Targeting an RNA Binding Protein Network in Glioblastoma by Decoy RNA Oligonucleotides
Our recent grants include:
- Shi-Yuan Cheng, PhD, PI
- NIH/NINDS: 1R01NS095634
- Autophagy Regulation of Glioblastoma Tumorigenesis and Responses to Therapy
- Shi-Yuan Cheng, PhD, Multi-PI, (MPI: Lesniak, M. and James, C.D.)
- P50 CA221747-01A1
- Enhancing GBM Cytotoxic Therapy Through Inhibition of Key Autophagy Mediator ATG4B
- Shi-Yuan Cheng, PhD, PI
- NIH/NINDS: R01NS093843
- Glioblastoma Phenotype Modulation through miRNA Control of Wnt Signaling
- Namratha Sastry, BS
- NIH/NCI: 1F31CA232630-01
- Novel Roles of LY6K in Glioblastoma Tumorigenesis